MedTrace Logo

Circulating Tumor Cells in mCRC for Liver Resection

NCT03295591 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2018-11-20

No results posted yet for this study

Summary

Resection of liver metastasis is potentially curative in patients with colorectal cancer bearing liver metastasis. However, early recurrence occurs in up to 30% in 3 months after liver resection. To optimize patient selection, the investigators propose to evaluate the the value of incorporating circulating tumor cells enumeration to clinical factors in a prospective study

Conditions

Interventions

DIAGNOSTIC_TEST

Circulating tumor cell

Circulating tumor cell enumeration and sequencing

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Ka On Lam, MBBS · The University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-11-30
Completion
2020-03-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03295591 on ClinicalTrials.gov